SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001485003-16-000076
Filing Date
2016-04-29
Accepted
2016-04-29 08:01:16
Documents
2
Period of Report
2016-06-08
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2016proxystatement.htm DEF 14A 509158
2 ebiologoa03.jpg GRAPHIC 89522
  Complete submission text file 0001485003-16-000076.txt   633370
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 161602558
SIC: 2834 Pharmaceutical Preparations